Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study42

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study32

Views

Views
January 20251
February 20251
March 202515
April 20252
May 20253
June 202510
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United Kingdom3
United States2
Germany1
Spain1
 

Top cities views

Views
Hong Kong10
Council Bluffs1
Nuremberg1